Meanwhile, the BSE Sensex was down 32.78 points, or 0.21%, to 15,902.83.

On BSE, 3192 shares were traded in the counter as against an average daily volume of 65,387 shares in the past one quarter.

The stock hit a high of Rs 1122.20 and a low of Rs 1103.15 so far during the day. The stock had hit a 52-week high of Rs 1255.65 on 14 January 2010 and a 52-week low of Rs 357 on 5 March 2009.

The stock had outperformed the market over the past one month till 8 February 2010, falling 6.46% compared with the Sensex's 9.15% fall. It outperformed the market in past one quarter, rising 4.59% as against 1.38% decline in the Sensex.

The large-cap drug maker has an equity capital of Rs 84.41 crore. Face value per share is Rs 5.

The current price of Rs 1104 discounts the company's Q3 December 2009 annualised EPS of Rs 39.91, by a PE multiple of 27.66.

Dr.Reddy's Laboratories' net profit rose 62.5% to Rs 168.42 crore on a 0.6% rise in sales to Rs 1041.31 crore in Q3 December 2009 over Q3 December 2008.

Dr Reddy's Lab is engaged in manufacturing and marketing pharmaceutical products. The group operates in seven segments: generics, active pharmaceutical ingredients (API) and intermediates, formulations, critical care and biotechnology, custom pharmaceutical services, drug discovery and others.